Skip to main content

Table 4 Odds ratios for antidepressant medications and Clostridium difficile infection in hospitalized adults

From: Depression, antidepressant medications, and risk of Clostridium difficileinfection

Ā Ā 

Unadjusted

Adjusteda

Medications

Using medication, n

OR

95% CI

P value

OR

95% CI

P value

Noradrenergic and specific serotonergic anti-depressants

ā€ƒMirtazapine

Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰Use (versus no use)

99

2.11

1.29 to 3.45

0.003

2.14

1.30 to 3.52

0.003

ā€ƒā€‰Doses given, n

Ā 

1.08

1.01 to 1.16

0.018

1.08

1.01 to 1.16

0.020

Selective serotonin reuptake inhibitors

ā€ƒFluoxetine

Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰Use (versus no use)

99

1.98

1.20 to 3.26

0.008

1.92

1.16 to 3.17

0.012

ā€ƒā€‰Doses given, n

Ā 

1.06

1.00 to 1.12

0.036

1.06

1.00 to 1.12

0.046

ā€ƒEscitalopram

Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰Use (versus no use)

80

0.97

0.48 to 1.95

0.929

0.98

0.48 to 1.97

0.945

ā€ƒā€‰Doses given, n

Ā 

1.04

0.98 to 1.10

0.191

1.04

0.98 to 1.09

0.234

ā€ƒCitalopram

Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰Use (versus no use)

310

0.90

0.62 to 1.32

0.599

0.90

0.62 to 1.31

0.569

ā€ƒā€‰Doses given, n

Ā 

0.99

0.94 to 1.04

0.620

0.98

0.94 to 1.04

0.566

ā€ƒSertraline

Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰Use (versus no use)

207

0.90

0.58 to 1.42

0.666

0.88

0.56 to 1.39

0.583

ā€ƒā€‰Doses given, n

Ā 

0.98

0.93 to 1.04

0.486

0.98

0.92 to 1.04

0.461

ā€ƒParoxetine

Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰Use (versus no use)

78

0.87

0.42 to 1.82

0.716

0.86

0.41 to 1.80

0.692

ā€ƒā€‰Doses given, n

Ā 

0.98

0.88 to 1.09

0.693

0.98

0.88 to 1.09

0.680

Tricyclic anti-depressants

ā€ƒNortriptyline

Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰Use (versus no use)

49

1.98

0.98 to 4.00

0.056

1.96

0.97 to 3.97

0.062

ā€ƒā€‰Doses given, n

Ā 

1.11

1.02 to 1.20

0.015

1.11

1.02 to 1.20

0.017

ā€ƒAmitriptyline

Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰Use (versus no use)

63

1.45

0.73 to 2.88

0.284

1.43

0.72 to 2.84

0.307

ā€ƒā€‰Doses given, n

Ā 

1.04

0.96 to 1.14

0.337

1.04

0.96 to 1.14

0.343

Serotonin antagonist and reuptake inhibitors

ā€ƒTrazodone

Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰Use (versus no use)

405

1.23

0.91 to 1.66

0.182

1.21

0.90 to 1.65

0.211

ā€ƒā€‰Doses given, n

Ā 

1.04

0.98 to 1.10

0.184

1.04

0.98 to 1.10

0.197

Serotonin-norepinephrine reuptake inhibitors

ā€ƒDuloxetine

Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰Use (versus no use)

82

1.19

0.63 to 2.26

0.597

1.15

0.60 to 2.19

0.681

ā€ƒā€‰Doses given, n

Ā 

1.01

0.94 to 1.09

0.690

1.01

0.94 to 1.09

0.788

ā€ƒVenlafaxine

Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰Use (versus no use)

58

0.72

0.29 to 1.81

0.482

0.71

0.28 to 1.78

0.464

ā€ƒā€‰Doses given, n

Ā 

1.05

0.95 to 1.16

0.367

1.05

0.94 to 1.16

0.401

Norepinephrine-dopamine reuptake inhibitors

ā€ƒBupropion

Ā Ā Ā Ā Ā Ā Ā 

ā€ƒā€‰Use (versus no use)

97

1.08

0.59 to 2.00

0.801

1.02

0.55 to 1.89

0.948

ā€ƒā€‰Doses given, n

Ā 

0.95

0.85 to 1.06

0.357

0.94

0.85 to 1.05

0.306

  1. a. Adjusted for age, gender, race, antibacterial medications, PPIs, H2RAs, statins, irritable bowel syndrome, celiac disease, Crohnā€™s disease, and ulcerative colitis.